Related references
Note: Only part of the references are listed.Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
IgY-turning the page toward passive immunization in COVID-19 infection (Review)
Carolina Constantin et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
An approach towards development of monoclonal IgY antibodies against SARS CoV-2 spike protein (S) using phage display method: A review
Rajeswari Somasundaram et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model
Aymn T. Abbas et al.
VACCINES (2020)
Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors
W. Widagdo et al.
JOURNAL OF VIROLOGY (2019)
IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
Aymn Talat Abbas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi et al.
SCIENTIFIC REPORTS (2019)
Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model
A. Jahangiri et al.
JOURNAL OF APPLIED MICROBIOLOGY (2019)
Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus
Naoko Lwata-Yoshikawa et al.
JOURNAL OF VIROLOGY (2019)
Inhalation of specific anti-Pseudomonas aeruginosa IgY antibodies transiently decreases P. aeruginosa colonization of the airway in mechanically ventilated piglets
A. Otterbeck et al.
INTENSIVE CARE MEDICINE EXPERIMENTAL (2019)
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
Ivy Widjaja et al.
EMERGING MICROBES & INFECTIONS (2019)
Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light
Salwa I. Hindawi et al.
TRANSFUSION (2018)
Features of chicken egg yolk immunoglobulin (IgY) against the infection of red-spotted grouper nervous necrosis virus
Lizhu Yi et al.
FISH & SHELLFISH IMMUNOLOGY (2018)
What's new in chicken egg research and technology for human health promotion? - A review
Grzegorz Lesnierowski et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2018)
Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
Myoung-don Oh et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Prospects for a MERS-CoV spike vaccine
Yusen Zhou et al.
EXPERT REVIEW OF VACCINES (2018)
Redox Biology of Respiratory Viral Infections
Olga A. Khomich et al.
VIRUSES-BASEL (2018)
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein
Hannah Kleine-Weber et al.
SCIENTIFIC REPORTS (2018)
Insights into the chicken IgY with emphasis on the generation and applications of chicken recombinant monoclonal antibodies
Warren Lee et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Infection in Camel Workers in Qatar During 2013-2014: A Case-Control Study
Reina S. Sikkema et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement
Ashley L. Fink et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates
Mohammed Farouk Yusof et al.
EMERGING MICROBES & INFECTIONS (2017)
Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
Mohamed A. Ali et al.
EMERGING MICROBES & INFECTIONS (2017)
Production and characterization of anti-Campylobacter jejuni IgY derived from egg yolks
Alexandre Thibodeau et al.
ACTA VETERINARIA SCANDINAVICA (2017)
Dromedary camels in northern Mali have high seropositivity to MERS-CoV
Darryl Falzarano et al.
ONE HEALTH (2017)
Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse model
Yongkun Zhao et al.
ANTIVIRAL RESEARCH (2017)
Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia
Jamal S. M. Sabir et al.
SCIENCE (2016)
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
Laura A. VanBlargan et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
Thomas Luke et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Exposures among MERS Case-Patients, Saudi Arabia, January-February 2016
Raafat F. Alhakeem et al.
EMERGING INFECTIOUS DISEASES (2016)
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Yan Li et al.
CELL RESEARCH (2015)
Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2015)
Middle East respiratory syndrome
Alimuddin Zumla et al.
LANCET (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure
Nicole Haese et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review
Xiaoyu Li et al.
JOURNAL OF ANIMAL SCIENCE AND BIOTECHNOLOGY (2015)
Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases - A review
U. Gadde et al.
ANIMAL HEALTH RESEARCH REVIEWS (2015)
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Fang Li
JOURNAL OF VIROLOGY (2015)
Avian IgY antibodies: characteristics and applications in immunodiagnostic
Livia Silveira Munhoz et al.
CIENCIA RURAL (2014)
Prophylaxis and therapy of pandemic H1N1 virus infection using egg yolk antibody
Yuan-e Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2014)
Evidence for Camel-to-Human Transmission of MERS Coronavirus
Christian Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment
Jan C. Varada et al.
VIROLOGY JOURNAL (2013)
Oral passive IgY-based immunotherapeutics A novel solution for prevention and treatment of alimentary tract diseases
Shofiqur Rahman et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Preparation and characterization of egg yolk immunoglobulin Y specific to influenza B virus
Junlin Wen et al.
ANTIVIRAL RESEARCH (2012)
Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy
Edzard Spillner et al.
BIOLOGICALS (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)
Rebecca Brocato et al.
PLOS ONE (2012)
Chicken egg yolk antibodies against bovine respiratory syncytial virus neutralize the virus in vitro
A. Ferella et al.
5TH VACCINE AND ISV ANNUAL GLOBAL CONGRESS (2012)
Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: A review
Yongping Xu et al.
BIOTECHNOLOGY ADVANCES (2011)
Cross-Protection of Chicken Immunoglobulin Y Antibodies against H5N1 and H1N1 Viruses Passively Administered in Mice
Michael G. Wallach et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1
Masaya Tsukamoto et al.
MOLECULAR MEDICINE REPORTS (2011)
Chicken monoclonal IgY antibody: a novel antibody development strategy
Xiaoying Zhang et al.
AVIAN BIOLOGY RESEARCH (2010)
Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice
Huan H. Nguyen et al.
PLOS ONE (2010)
Monitoring of laying capacity, immunoglobulin Y concentration, and antibody titer development in chickens immunized with ricin and botulinum toxins over a two-year period
D. Pauly et al.
POULTRY SCIENCE (2009)
Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice
Lili Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens
Chao-Yang Fu et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Chicken IgY: utilizing the evolutionary advantage
M Karlsson et al.
WORLDS POULTRY SCIENCE JOURNAL (2004)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis:: A phase I feasibility study
H Kollberg et al.
PEDIATRIC PULMONOLOGY (2003)